Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-18-0953
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Selective TRK Inhibitor CH7057288 Against TRK Fusion-Driven Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Targeting RET-driven Cancers: Lessons From Evolving Preclinical and Clinical Landscapes

Nature Reviews Clinical Oncology
Oncology
2017English

Data-Driven Process Discovery and Analysis

Lecture Notes in Business Information Processing
ControlSystems EngineeringInformation SystemsBusinessInternational ManagementSimulationManagementManagement Information SystemsModeling
2012English

Data-Driven Process Discovery and Analysis

Lecture Notes in Business Information Processing
ControlSystems EngineeringInformation SystemsBusinessInternational ManagementSimulationManagementManagement Information SystemsModeling
2018English

Targeting WNT-Driven Cancer Through the Inhibition of Porcupine by LGK974

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Data Driven Discovery of Cyber Physical Systems

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

A Verification and Validation Process for Model-Driven Engineering

2013English

Targeting TAZ-driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy